Houdini Bio
Houdini Bio

Houdini Bio

DR7Ahrefs DR: 7/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent30Agent Readiness: 30/100. Below median. Measured by StartupHub.ai. Median 41.Speed80Site Speed: 80/100. Top 25%. Measured by Google PageSpeed. Median 62.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

2025Active3Cambridge, United Kingdom

About

Houdini Bio is a DeepTech BioTech company providing critical enabling infrastructure for next-generation genetic medicines. Their platform combines machine learning with a mechanistic understanding of cellular silencing pathways to re-engineer therapeutic DNA. This approach aims to maximize transgene expression, durability, and scalability by making therapeutic DNA invisible to cellular defenses like the Human Silencing Hub (HUSH) complex, thereby improving the effectiveness and safety of genetic therapies.

Key facts

At-a-glance profile data

Website
houdinibio.com
Headquarters
Cambridge, England, United Kingdom
Founded
2025
Employees
3
Total funding
$2M (Pre-Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Houdini Bio
DateRoundAmountLead investors
1 Jun 2026Pre-Seed$2MSCVC

Tech stack

Detected on houdinibio.com, last scanned 10 Sept 2026. Run your own scan

CMS / Builders
Webflow
CDN
Cloudflare
Email provider
Google Workspace
Add first review

Frequently asked

How much funding has Houdini Bio raised?

Houdini Bio has raised a total of $2M in funding. The most recent round on record is Pre-Seed.

How many employees does Houdini Bio have?

Houdini Bio has approximately 3 people on record.